News Focus
News Focus
icon url

chickpea598

11/07/17 11:43 AM

#41136 RE: dr_lowenstein #41129

Amgen paid 1 billion to get their hands on T-Vec for melanoma. It is fair to say that Oncosec would fetch a similar price if Merck wants ep-il12 bad enough.